<DOC>
	<DOC>NCT01061853</DOC>
	<brief_summary>The purpose of this study is to determine wether topical rapamycin is more efficient than topical steroids in the treatment of chronic erosive lichen planus.</brief_summary>
	<brief_title>Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen</brief_title>
	<detailed_description />
	<mesh_term>Lichen Planus, Oral</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Oral Lichen Planus Oral Erosive Area More Than 1cmÂ² Lichen Planus Pathologically Proven No Previous Treatment by Rapamycin Non Child Bearing Or Breast Feeding Woman Patient Who Cannot Be Treated By Rapamycin Or Betamethasone Chronic Renal Insufficiency (Creatinin Clearance &lt; 40ml/Mn) Ongoing Treatment By Topical Calcineurin Inhibitors Or Systemic Steroids Or Retinoids Or Systemic Immunosuppressors Or Thalidomide Or Griseofulvin Or Antimalarials Cholesterolemia &gt;7.8 Mmol/L Or Hypertriglyceridemia &gt;3.95mmol/L Non Responsive To Medical Treatments Leucopenia (&lt;3000/Mm3) Thrombopenia (&lt;100 000/Mm3) Hypertransaminasemia (&gt;3n) Hypersensitivity To Macrolides</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Oral lichen planus</keyword>
	<keyword>chronic inflammatory</keyword>
	<keyword>mucous membranes</keyword>
	<keyword>erosive lesions</keyword>
</DOC>